Applications of IMAT in cervical esophageal cancer radiotherapy: A comparison with fixed-field IMRT in dosimetry and implementation

Journal of Applied Clinical Medical Physics

Volumn 12, Issue 2, 2011, Pages 48-57

  Yin, Yong ^a,b   Chen, Jinhu ^b   Xing, Ligang ^b   Dong, Xiaoling ^b   Liu, Tonghai ^b   Lu, Jie ^b   Yu, Jinming ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Dosimetry; Esophageal neoplasms; Intensity modulated arc radiotherapy; Intensity modulated radiotherapy

Indexed keywords

EID: 79960522991     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v12i2.3343     Document Type: Article

References (34)

1. Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M, Ringash J. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol. 2008;89(3):287-91.
2. Huang SH, Lockwood G, Brierley J, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys. 2008;71(3):735-40.
3. Yamada K, Murakami M, Okamoto Y, et al. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006;45(8):1120-25.
4. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys. 2000;46(1):195-205.
5. Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71(2):201-206.
6. Chandra A, Guerrero TM, Liu HH, et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol. 2005;77(3):247-53.
7. Gange IM, Ansbacher W, Zavgorodni S, Popescu C, Beckham WA. A Monta Carlo evaluation of RapidArc dose calculations for oropharynx radiotherapy. Phys Med Biol. 2008;53(24):7167-85.
8. Court LE, Ching D, Schofield D, Czerminska M, Allen AM. Evaluation of the dose calculation accuracy in intensity-modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung. J Appl Clin Med Phys. 2009;10(2):34-42.
9. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72(4):996-1001.
10. Cozzi L, Dinshaw KA, Shrivastava SK, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89(2):180-91.
11. Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Bogdanov M. Hybrid IMRT for treatment of cancers of the lung and esophagus. Int J Radiat Oncol Biol Phys. 2008;71(5):1408-18.
12. Li BQ, Li D, Lau DH, et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol. 2009;4(Nov 12):52.
13. Berger B, Belka C. Evidence-based radiation oncology: oesophagus. Radiother Oncol. 2009;92(2):276-90.
14. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. 1: dosimetric results. Int J Radiation Oncology Biol Phys. 2003;56(2):573-85.
15. Baltas D, Kolotas C, Geramani K, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiation Oncology Biol Phys. 1998;40(2):515-24.
16. Shepard DM, Earl MA, Li XA, Naqvi S, Yu C. Direct aperture optimization: a turnkey solution for step-and-shoot IMRT. Med Phys. 2002;29(6):1007-18.
17. Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol. 1988;12(2):129-40.
18. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58(4):1268-79.
19. Hall EJ. Intensity-modulated radiation therapy, proton, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1-7.
20. Mu X, Löfroth PO, Karlsson M, Zackrisson B. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. Radiother Oncol. 2003;68(2):181-87.
21. Moiseenko V, Duzenli C, Durand RE. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery. Med Phys. 2007;34(4):1514-20.
22. Keall PJ, Chang M, Benedict S, Thames H, Vedam SS, Lin PS. Investigating the temporal effects of respiratory-gated and intensity-modulated radiotherapy treatment delivery on in vitro survival: an experimental and theoretical study. Int J Radiat Oncol Biol Phys. 2008;71(5):1547-52.
23. Paganetti H. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;63(3):892-900.
24. Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol. 2009;93(3):593-96.
25. Nutting CM, Bedford JL, Cosgrove VP, Tait DM, Dearnaley DP, Webb S. Intensity-modulated radiotherapy reduces lung irradiation in patients with carcinoma of the oesophagus. Front Radiat Ther Oncol. 2002;37:128-31.
26. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66(5):1399-407.
27. Wang SL, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int JRadiat Oncol Biol Phys. 2006;64(3):692-99.
28. Gopal R, Tucker SL, Komaki R, et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys. 2003;56(1):106-13.
29. Yorke ED, Jackson A, Rosenzweig KE, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002;54(2):329-39.
30. Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J RadiatOncol Biol Phys. 2006;65(4):1075-86.
31. Otto K. Volumetric modulated arc therapy: IMRT in a single arc. Med Phys. 2008;35(1):310-17.
32. Luan S, Wang C, Cao D, Chen DZ, Shepard DM, Yu CX. Leaf-sequencing for intensity-modulated arc therapy using graph algorithms. Med Phys. 2008;35(1):61-69.
33. Vanetti E, Clivio A, Nicolini G, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92(1):111-17.
34. Wang C, Luan S, Tang G, Chen DZ, Earl MA, Yu CX. Arc-modulated radiation therapy (AMRT): a single-arc form of intensity-modulated arc therapy. Phys Med Biol. 2008;53(22):6291-303.